ZURA

NASDAQ · Biotechnology

Zura Bio Ltd

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.63

-0.15 (-2.60%)

As of Aug 15, 2:03 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +310.7% upside

Low Target $15.51

Average Target $23.12

High Target $31.84

Current Price $5.63

Current
$5.63

Target
$23.12

$15.51 $23.12 avg $31.84

Scenario Analysis

Bear Case

$15.51

175.5%

Low target

Base Case

$23.12

+310.7%

Avg target

Bull Case

$31.84

+465.5%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$7.44

-24.3% from high

52-Week Low

$1.47

+283.1% from low

Target vs 52W High

$23.12

+210.8% vs high

Next Earnings Report

Aug 19, 2026

until earnings

EPS Est: $-0.20

Earnings in 3 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%